Loading…
FC Company Limited, a medical device manufacturer, received an FDA Warning Letter on September 30, 2025, citing two violations. While the specific nature of these violations cannot be determined from the available metadata—as the detailed subject line and issuing office information are not provided—the warning indicates regulatory concerns with the company's device operations. This enforcement action falls under FDA's medical device regulatory authority, though additional context from the full letter would be needed to identify the specific product categories or compliance issues involved.